Estudios científicos

Efecto protector del hialuronato frente a la toxicidad inducida por formulaciones antiglaucomatosas libres de conservantes

– Por Pizzano Manuela

In vitro evaluation of the protective effect of sodium hyaluronate against toxicity induced by antiglaucomatous formulations

– Por Passerini Silvia

Triple-fixed Combination of Dorzolamide/Timolol/Brimonidine: Efficacy Study in Bolivian Population

– Por Justiniano Manuel José

Hyaluronate Protects From Benzalkonium Chloride-InducedOcular Surface Toxicity

– Por Vereertbrugghen Alexia

(ARVO 2023) Sodium hyaluronate improves corneal reinnervation and epithelial healingin anin vivo benzalkonium chloride (BAK)-induced toxicity model

– Por del Papa Melina

El Hialuronato de Sodio protege de la toxicidad corneal del BAKen un modelo in vivo

– Por del Papa Melina

(WGC 2023) Sodium hyaluronate improves corneal reinnervation and epithelial healingin anin vivo benzalkonium chloride (BAK)-induced toxicity model

– Por Passerini Silvia

Evaluation of the osmoprotective and bioprotective effect of trehalose 3%

– Por Sendra Víctor

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis

– Por Marini Cecilia

Efecto del hialuronato de sodio 0,4% sobre la regeneración nerviosa corneal en presencia del cloruro de benzalconio

– Por Vereertbrugghen Alexia

(EVER 2022) In vitro evaluation of sodium hyaluronate protective effect against benzalkonium chloride toxicity

– Por del Papa Melina

(EGS 2022) In vitro evaluation of sodium hyaluronate protective effect against benzalkonium chloride toxicity

– Por Passerini Silvia

Evaluation of the osmoprotective and bioprotective effect of trehalose 3%

– Por Passerini Silvia

Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day forcataract postsurgical inflammation treatment:noninferiority trial

– Por Valvecchia Gerardo

A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study

– Por Tau Julia

Cytotoxicity evaluation of a novel latanoprost 0.005% nanoemulsion

– Por del Papa Melina

A Comparative Study of Difluprednate 0.05% Nanoemulsion Vs Prednisolone Acetate 1% + Phenylephrine 0.12% Suspension on Postoperative Inflammation Treatment Following Cataract Surgery

– Por Valvecchia Gerardo

Evaluación in vitro del efecto protector del hialuronato de sodio frente a la toxicidad inducida por el cloruro de benzalconio

– Por Sabbione Florencia

Efficacy and Tolerability of a New Latanoprost 0.005%BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

– Por Casiraghi Javier

(2018) Efficacy and tolerability of a new thermostable formulation of latanoprost in nanoparticles

– Por Rodríguez Lourdes

Eficacia y tolerabilidad de un latanoprost en nanopartículas termoestable

– Por Peyret Alejo

Eficacia y tolerabilidad de una nueva formulación termoestable de latanoprost en nanopartículas

– Por Grigera Daniel

(2019) Efficacy and tolerability of a new thermostable formulation of latanoprost in nanoparticles

– Por Passerini Silvia

Latanoprost en nanoemulsión: una nueva opción terapéutica

– Por Grigera Daniel

Estudios científicos

Efecto protector del hialuronato frente a la toxicidad inducida por formulaciones antiglaucomatosas libres de conservantes

In vitro evaluation of the protective effect of sodium hyaluronate against toxicity induced by antiglaucomatous formulations

Triple-fixed Combination of Dorzolamide/Timolol/Brimonidine: Efficacy Study in Bolivian Population

Hyaluronate Protects From Benzalkonium Chloride-InducedOcular Surface Toxicity

(ARVO 2023) Sodium hyaluronate improves corneal reinnervation and epithelial healingin anin vivo benzalkonium chloride (BAK)-induced toxicity model

El Hialuronato de Sodio protege de la toxicidad corneal del BAKen un modelo in vivo

(WGC 2023) Sodium hyaluronate improves corneal reinnervation and epithelial healingin anin vivo benzalkonium chloride (BAK)-induced toxicity model

Evaluation of the osmoprotective and bioprotective effect of trehalose 3%

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis

Efecto del hialuronato de sodio 0,4% sobre la regeneración nerviosa corneal en presencia del cloruro de benzalconio

(EVER 2022) In vitro evaluation of sodium hyaluronate protective effect against benzalkonium chloride toxicity

(EGS 2022) In vitro evaluation of sodium hyaluronate protective effect against benzalkonium chloride toxicity

Evaluation of the osmoprotective and bioprotective effect of trehalose 3%

Difluprednate 0.05% twice a day vs prednisolone acetate 1% 4 times a day forcataract postsurgical inflammation treatment:noninferiority trial

A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study

Cytotoxicity evaluation of a novel latanoprost 0.005% nanoemulsion

A Comparative Study of Difluprednate 0.05% Nanoemulsion Vs Prednisolone Acetate 1% + Phenylephrine 0.12% Suspension on Postoperative Inflammation Treatment Following Cataract Surgery

Evaluación in vitro del efecto protector del hialuronato de sodio frente a la toxicidad inducida por el cloruro de benzalconio

Efficacy and Tolerability of a New Latanoprost 0.005%BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial

(2018) Efficacy and tolerability of a new thermostable formulation of latanoprost in nanoparticles

Eficacia y tolerabilidad de un latanoprost en nanopartículas termoestable

Eficacia y tolerabilidad de una nueva formulación termoestable de latanoprost en nanopartículas

(2019) Efficacy and tolerability of a new thermostable formulation of latanoprost in nanoparticles

Latanoprost en nanoemulsión: una nueva opción terapéutica

Información de contacto

Email

Dirección

Legal